Tyra Bioscience's market cap is currently $691.26M. The company's EPS TTM is $-0.47; its P/E ratio is ―; Tyra Bioscience is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-0.50. See an overview of income statement, balance sheet, and cash flow financials.
